Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flow

v2.4.0.6
Consolidated Statements of Cash Flow (USD $)
In Millions, unless otherwise specified
 3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Operating Activities    
Net income $ 14.6 $ 31.3
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 15.0 12.2
Deferred income taxes 4.7 (9.6)
Equity in net loss from affiliates 0.2 0.1
Share-based compensation 4.5 5.3
Trade accounts receivable and receivables on long-term manufacturing contracts 4.3 9.3
Inventories 8.4 (6.7)
Other current assets (8.3) (3.0)
Trade accounts payable 0.2 (4.2)
Accrued expenses and other current liabilities (25.3) (15.8)
Income taxes payable (1.2) 5.6
Defined benefit plan funding (1.2) (0.6)
Defined benefit plan expense 3.8 3.1
Net cash provided by operating activities 19.7 27.0
Investing Activities    
Capital expenditures (5.6) (4.2)
Proceeds on sales of property, plant, and equipment 1.2  
Proceeds from sales of investments 1.4  
Acquisition of business, net of cash acquired (415.6)  
Net cash used in investing activities (418.6) (4.2)
Financing Activities    
Proceeds from term loan 200.0  
Repayments on term loan (2.5)  
Proceeds from revolving credit facilities, net of financing costs 535.3  
Repayments on revolving credit facilities (238.0)  
Payment of dividends on common stock (12.1) (11.9)
Other, net (2.7) (1.7)
Net cash provided by (used in) financing activities 480.0 (13.6)
Effect of exchange rates on cash and cash equivalents 0.8 (2.2)
Net cash flow 81.9 7.0
Cash and cash equivalents    
At beginning of period 20.2 115.5
At end of period $ 102.1 $ 122.5